Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.

Hinterleitner C, Barthet VJA, Goldberg HV, Vogt KC, Perea AM, Hillger LR, Ruiz S, McHugh D, Ho YJ, Chaves-Perez A, Skamagki M, Flowers S, Styers HC, Rekhtman N, Zhuang X, Dessotti Barretto G, Li X, Watson JT, Luan W, Simon J, Tammela T, Gardner R, Rudin CM, Romesser PB, Bott MJ, Filliol A, Heller DA, Lowe SW

Open source

DOI: 10.1126/science.aeg4791
Published: 2026 Sep 24
Container: Science (New York, N.Y.)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/science.aeg4791,
  title = {Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.},
  author = {Hinterleitner C and Barthet VJA and Goldberg HV and Vogt KC and Perea AM and Hillger LR and Ruiz S and McHugh D and Ho YJ and Chaves-Perez A and Skamagki M and Flowers S and Styers HC and Rekhtman N and Zhuang X and Dessotti Barretto G and Li X and Watson JT and Luan W and Simon J and Tammela T and Gardner R and Rudin CM and Romesser PB and Bott MJ and Filliol A and Heller DA and Lowe SW},
  year = {2026},
  journal = {Science (New York, N.Y.)},
  doi = {10.1126/science.aeg4791},
  url = {https://doi.org/10.1126/science.aeg4791}
}

RIS

TY  - JOUR
TI  - Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.
AU  - Hinterleitner C
AU  - Barthet VJA
AU  - Goldberg HV
AU  - Vogt KC
AU  - Perea AM
AU  - Hillger LR
AU  - Ruiz S
AU  - McHugh D
AU  - Ho YJ
AU  - Chaves-Perez A
AU  - Skamagki M
AU  - Flowers S
AU  - Styers HC
AU  - Rekhtman N
AU  - Zhuang X
AU  - Dessotti Barretto G
AU  - Li X
AU  - Watson JT
AU  - Luan W
AU  - Simon J
AU  - Tammela T
AU  - Gardner R
AU  - Rudin CM
AU  - Romesser PB
AU  - Bott MJ
AU  - Filliol A
AU  - Heller DA
AU  - Lowe SW
PY  - 2026
JO  - Science (New York, N.Y.)
DO  - 10.1126/science.aeg4791
UR  - https://doi.org/10.1126/science.aeg4791
ER  -

APA

C, H., VJA, B., HV, G., KC, V., AM, P., LR, H., S, R., D, M., YJ, H., A, C., M, S., S, F., HC, S., N, R., X, Z., G, D. B., X, L., JT, W., W, L., J, S., T, T., R, G., CM, R., PB, R., MJ, B., A, F., DA, H., & SW, L. (2026). Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer.. Science (New York, N.Y.). https://doi.org/10.1126/science.aeg4791

Source records

pubmed · retrieved 2026-09-25T10:34:35.504Z